PE-Backed Biotech Co. UniQure Eyes $75M IPO
Dutch biotech company uniQure plans to make a U.S. public offering to raise up to $75 million in capital, according to U.S. Securities and Exchange Commission filings Thursday....To view the full article, register now.
Already a subscriber? Click here to view full article